Skip to contentE
ENvue Medical, Inc.
E
FEEDENvue Medical, Inc. Released Mar 31, 2017, during market hours
10-K filed Mar 31, 2017, 90 days after period end · 0001144204-17-018057
Q4 2016 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$49.00K$49.00Kderived+25.6% vs Q4 2015 No earnings release is on file for this quarter. Its figures came with the 10-K.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ENvue Medical, Inc. · CIK 1326706 · Engraved from SEC EDGAR
−19.7% vs Q3 2016
Net Income-$1.12M-$1.12MderivedN/M vs Q4 2015N/M vs Q3 2016 EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$37,000+48.0% Operating Incomederived-$841,000N/M Operating Cash Flowderived-$426,000N/M Free Cash Flowderived-$426,000N/M Margins · derivedGross margin75.5%+11.4 pt vs Q4 2015
Operating margin-1716.3%−536.8 pt vs Q4 2015
Net margin-2285.7%−283.2 pt vs Q4 2015
ended Dec 31, 2016 · filed Mar 31, 2017 · 90 d after period end